Our previous study demonstrated that PKG II could inhibit the activation of some key members of the RTK family, including EGFR, VEGFR, PDGFR and IGF-1R, and the consequent signal transduction in gastric cancer cells [24]. This evidence concerns the gene PDGFRB and gastric cancer.